Microbiome Market - By Type (Microbial Drugs, Fecal Microbiota Transplantation), By Application (Infectious Diseases, Cancers, Gastrointestinal Disorders, Metabolic Diseases and Others), By End User (Human Therapeutics, Human Diagnostics, Agriculture & Environmental, Food & Feed, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $4000 | Pages : 313 | Published : May 2021 | SKU CODE : o&s263 | Format :

Request Sample

Microbiome Market Definition

The microbiome market consists of sales of microbiomes used for manufacturing micro based end products, and microbiome-based research and development services by entities involved in manufacturing and/or research and development on microbiomes.


The microbiome consists of the genetic material within a microbiota, which is the collection of microorganisms, such as bacteria, archaea, fungi, and viruses living in humans, animals, plants, soil and other habitats. For example, the gut microbiome consists of collective genome of microbes inhabiting the gut. Microbiomes are also known as the metagenome of the microbiota.

Microbiome Market Size

The global microbiome market reached a value of nearly $4,977.2 million in 2020, having increasing at a compound annual growth rate (CAGR) of 12.6% since 2015. The market is expected to grow at a CAGR of 12.7% from 2020 to reach $9,061.0 million in 2025.  The global microbiome market is expected to reach $15,554.8 million in 2030, at a CAGR of 11.4%.

Growth in the historic period resulted from government initiatives, increased need for immunology, rise in funding, increased healthcare expenditure, increase in use of biopesticides, increased usage of microbiome based cosmetic products, and rising awareness about antibiotic free animal products. Factors that negatively affected growth in the historic period were pricing pressures and lack of awareness on microbiome.

Going forward, increasing funding, technological advances, increase in healthcare access, rising prevalence of chronic diseases and use of microbiome for improving animal production will drive growth. Factors that could hinder the growth of the microbiome market in future include ethical concerns related to genomic study.

Microbiome Market Drivers

The key drivers of the microbiome market include:

Increased Usage Of Microbiome Based Cosmetic Products

The usage of microbiome-based skin products is a driver for the microbiome market. The increased environmental stressors, pollution, and fear of chemicals, is driving consumers towards microbiome-based skincare. The skincare market has embraced distinct approaches, targeting the skin microbiome such as probiotics, prebiotics, postbiotics. These products help in anti-aging of skin by improving the quality of skin, accelerating its renewal process, and supporting the shedding of dead skin cells. Microbiome-based cosmetics can also help prevent dandruff, acne, psoriasis, or atopic dermatitis. The multiple benefits of microbiome based cosmetic products is promoting the use of these products. For instance, from 2013 to 2017, the use of Lactobacillus-based probiotic skincare products increased by 98% in the United States.

Microbiome Market Restraints

The key restraints on the microbiome market include:

Pricing Pressures From Regulators

Regulatory agencies and governments have taken a tougher stance on drug pricing by biopharmaceutical companies. Biologics companies are also facing criticism from politicians, patients and physicians over the pricing of some medicines. Companies were finding it difficult to defend their pricing despite citing high development costs. This has limited the growth of the market for microbiomes during the historic period.

Microbiome Market Trends

Major trends influencing the microbiome market include:

Strategic Collaborations And Agreements

Companies in the microbiome market are strategically partnering and collaborating with other companies to broaden their product portfolios and expand their microbiome therapeutics business. For instance, in November 2019, Enterome, a France-based leading player in the microbiome market entered into collaboration with Memorial Sloan Kettering Cancer Canter (MSK), a US-based research institute to develop cancer immunotherapies from gut microbiome-derived antigens.  Also, in 2018, Microbiotica, a leading player in the market entered into a collaboration with Genentech to develop microbiome therapeutics to treat inflammatory bowel disease.

Increasing Investments In Development Of Cancer Microbiome Therapeutics

Companies in microbiome market are increasingly investing on the development of cancer microbiome therapeutics. Many companies in the industry are receiving investments from different venture capital firms to develop oncology microbiome therapeutics. For instance, in 2015, Evelo Therapeutics, a US company, received venture capital of about $35 million for the development of microbiomes for lung, skin, prostate and colon cancer.  Also, in 2020, Enterome, a leading player in the global microbiome market, in a series of funding raised Euro 46.3 million ($54.7 million) to invest in the clinical trials for microbiome therapies to treat inflammatory diseases and cancer.

Opportunities And Recommendations In The Microbiome Market

Opportunities –The top opportunities in the microbiome market segmented by end use will arise in the agriculture and environmental segment, which will gain $1,820.0 million of global annual sales by 2025. The top opportunities in the human microbiome therapeutics market segmented by type will arise in the microbial drugs segment, which will gain $37.6 million of global annual sales by 2025.  The top opportunities in the human microbiome therapeutics market segmented by application will arise in the infectious disease segment, which will gain $183.5 million of global annual sales by 2025.The microbiome market size will gain the most in the USA at $790.4 million.

Recommendations-To take advantage of these opportunities, The Business Research Company recommends the microbiomes manufacturing companies to consider development of cancer microbiome therapeutics and strategic partnerships and collaborations to improve technical and research expertise, establishing operations in emerging markets to gain market share, offer competitive pricing, partner with big brands and focus on end-use industries among other strategies.

Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, United States

Microbiome Market Segmentation

The microbiome market is segmented by type, by end use industry, by application and by geography.
By End Use Industry-
The microbiome market is segmented by end use industry into
    • a) Human Therapeutics
    • b) Human Diagnostics
    • c) Agriculture & Environmental
    • d) Food & Feed
    • e) Others
The agriculture & environmental market was the largest segment of the microbiome market segmented by end use, accounting for 39.2% of the total in 2020. Going forward, the human diagnostics segment is expected to be the fastest growing segment in the microbiome market segmented by end use, at a CAGR of 18.0% during 2020-2025.
By Type –
The microbiome market is segmented by type into
    • a) Microbial Drugs
    • b) Fecal Microbiota Transplantation (FMT)
The microbial drugs market was the largest segment of the human microbiome therapeutics market segmented by type, accounting for 70.9% of the total in 2023. Going forward, it is also expected to be the fastest growing segment in the microbiome market segmented by platform, at a CAGR of 22.4% during 2020-2025.
By Application -
The microbiome market is segmented by application into
    • a) Infectious Diseases
    • b) Cancers
    • c) Gastrointestinal Disorders
    • d) Metabolic Diseases
    • e) Others
The infectious diseases market was the largest segment of the microbiome market segmented by application, accounting for 100% of the total in 2023.
By Geography -The microbiome market is segmented into
      o North America
      • • USA
      o Western Europe,
      • • UK
      • • Germany
      • • France
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o Eastern Europe
      • • Russia
      o South America
      • • Brazil
      o Middle East
      o Africa
Asia-Pacific was the largest region in the global microbiome market, accounting for 37.2% share of the total in 2020. It was followed by North America, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the microbiome market will be South America and Africa.

Microbiome Competitive Landscape

Major Competitors are:

  • • Assembly Biosciences
  • • Enterome Bioscience
  • • Ferring Pharmaceutical
  • • Vedanta BioSciences
  • • Seres Therapeutics

Other Competitors Include:

  • • Microbiotica
  • • Rebiotix, Inc
  • • Locus Biosciences
  • • Second Genome Inc.
  • • Osel Inc.
  • • Second Genome
  • • Kallyope
  • • Finch Therapeutics
  • • Concentric
  • • AOBiome, Enterome
  • • Yakult Honsha Co., Ltd
  • • MicroBiome Therapeutics LLC
  • • Metabiomics Corporate
  • • Synthetic Biologics, Inc.
  • • DuPont, BiomX Ltd
  • • MaaT Pharma
  • • Eligo Bioscience
  • • SNIPR Biome
  • • Ritter Pharmaceuticals
  • • DayTwo
  • • Yeda Research and Development Co. Ltd
  • • MyBiome

    1. Microbiome Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Segmentation By End Use Industry

    6.3. Segmentation By Type

    6.4. Segmentation By Application

    7. Microbiome Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By End Use Industry

    7.2.1. Human Therapeutics

    7.2.2. Human Diagnostics

    7.2.3. Agriculture And Environmental

    7.2.4. Food And Feed

    7.2.5. Others

    7.3. Human Microbiome Therapeutics

    7.3.1. Fecal Microbiota Transplantation (FMT)

    7.3.2. Microbiome Drugs

    7.3.3. Infectious Diseases

    7.3.4. Gastrointestinal Disorders

    7.3.5. Metabolic Disorders

    7.3.6. Cancers

    7.3.7. Other Diseases

    8. COVID-19 Impact On The Microbiome Market

    9. Microbiome Market Trends And Strategies

    9.1. Strategic Collaborations And Agreements

    9.2. Increasing Number Of Pipeline Studies And Drug Development

    9.3. Increasing Investments In Development Of Cancer Microbiome Therapeutics

    9.4. End-Use Industry Trends

    9.4.1. Increasing Research On Microbiomes In Agriculture

    9.4.2. Increasing Demand Of Probiotics

    9.4.3. Skin Microbiome Products

    10. Global Microbiome Market Size And Growth

    10.1. Market Size

    10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

    10.2.1. Drivers Of The Market 2015 – 2020

    10.2.2. Restraints On The Market 2015 – 2020

    10.3. Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    10.3.1. Drivers Of The Market 2020 – 2025

    10.3.2. Restraints On The Market 2020 – 2025

    11. Global Microbiome Market Segmentation

    11.1. Global Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    11.1.1. Agriculture & Environmental

    11.1.2. Others

    11.1.3. Food & Feed

    11.1.4. Human Diagnostics

    11.1.5. Human Therapeutics

    11.1.6. Global Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    11.1.7. Global Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    11.1.8. Infectious Diseases

    11.1.9. Cancers

    11.1.10. Gastrointestinal Disorders

    11.1.11. Metabolic Disorders

    12. Microbiome Market, Regional And Country Analysis

    12.1. Global Microbiome Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    12.2. Global Microbiome Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13. Asia-Pacific Microbiome Market

    13.1. Asia-Pacific Microbiome Market Overview

    13.1.1. Region Information

    13.1.2. Impact of COVID-19

    13.1.3. Market Information

    13.1.4. Background Information

    13.1.5. Government Initiatives

    13.1.6. Regulations

    13.1.7. Regulatory Bodies

    13.1.8. Major Associations

    13.1.9. Taxes Levied

    13.1.10. Corporate Tax Structure

    13.1.11. Investments

    13.1.12. Major Companies

    13.2. Asia-Pacific Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.3. Asia-Pacific Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.4. Asia-Pacific Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.4.1. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.4.2. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    13.5. Asia-Pacific Microbiome Market: Country Analysis

    13.6. China Microbiome Market

    13.7. China Microbiome Market Overview

    13.7.1. Country Information

    13.7.2. Impact of COVID-19

    13.7.3. Market Information

    13.7.4. Background Information

    13.7.5. Government Initiatives

    13.7.6. Regulations

    13.7.7. Regulatory Bodies

    13.7.8. Major Associations

    13.7.9. Corporate Tax Structure

    13.7.10. Investments

    13.7.11. Major Companies

    13.8. China Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.9. China Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.10. China Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.10.1. China Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.10.2. China Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    13.11. India Microbiome Market

    13.12. India Microbiome Market Overview

    13.12.1. Country Information

    13.12.2. Impact of COVID-19

    13.12.3. Market Information

    13.12.4. Background Information

    13.12.5. Government Initiatives

    13.12.6. Regulations

    13.12.7. Regulatory Bodies

    13.12.8. Major Associations

    13.12.9. Corporate Tax Structure

    13.12.10. Major Companies

    13.13. India Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.14. India Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.15. India Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.15.1. India Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.15.2. India Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    13.16. Japan Microbiome Market

    13.17. Japan Microbiome Market Overview

    13.17.1. Country Information

    13.17.2. Impact of COVID-19

    13.17.3. Market Information

    13.17.4. Background Information

    13.17.5. Government Initiatives

    13.17.6. Regulations

    13.17.7. Regulatory Bodies

    13.17.8. Corporate Tax Structure

    13.17.9. Investments

    13.17.10. Major Companies

    13.18. Japan Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.19. Japan Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.20. Japan Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.20.1. Japan Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.20.2. Japan Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    13.21. Australia Microbiome Market

    13.22. Australia Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.23. Australia Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.24. Australia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.24.1. Australia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.24.2. Australia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    13.25. Indonesia Microbiome Market

    13.26. Indonesia Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.27. Indonesia Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.28. Indonesia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.28.1. Indonesia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.28.2. Indonesia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    13.29. South Korea Microbiome Market

    13.30. South Korea Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    13.31. South Korea Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    13.32. South Korea Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    13.32.1. South Korea Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    13.32.2. South Korea Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    14. Western Europe Microbiome Market

    14.1. Western Europe Microbiome Market Overview

    14.1.1. Region Information

    14.1.2. Impact Of COVID-19

    14.1.3. Market Information

    14.1.4. Background Information

    14.1.5. Government initiatives

    14.1.6. Regulations

    14.1.7. Regulatory Bodies

    14.1.8. Major Associations

    14.1.9. Taxes Levied

    14.1.10. Corporate Tax Structure

    14.1.11. Investments

    14.1.12. Major Companies

    14.2. Western Europe Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.3. Western Europe Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.4. Western Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.4.1. Western Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    14.4.2. Western Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    14.5. Western Europe Microbiome Market: Country Analysis

    14.6. UK Microbiome Market

    14.7. UK Microbiome Market Overview

    14.7.1. Country Information

    14.7.2. Impact Of COVID-19

    14.7.3. Market Information

    14.7.4. Background Information

    14.7.5. Government Initiatives

    14.7.6. Regulations

    14.7.7. Regulatory Bodies

    14.7.8. Major Associations

    14.7.9. Taxes Levied

    14.7.10. Corporate Tax Structure

    14.7.11. Investments

    14.7.12. Major Companies

    14.8. UK Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.9. UK Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.10. UK Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.10.1. UK Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    14.10.2. UK Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    14.11. Germany Microbiome Market

    14.12. Germany Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.13. Germany Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.14. Germany Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.14.1. Germany Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    14.14.2. Germany Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    14.15. France Microbiome Market

    14.16. France Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    14.17. France Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    14.18. France Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    14.18.1. France Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    14.18.2. France Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    15. Eastern Europe Microbiome Market

    15.1. Eastern Europe Microbiome Market Overview

    15.1.1. Region Information

    15.1.2. Impact Of COVID-19

    15.1.3. Market Information

    15.1.4. Background Information

    15.1.5. Regulations

    15.1.6. Regulatory Bodies

    15.1.7. Major Associations

    15.1.8. Taxes Levied

    15.1.9. Corporate Tax Structure

    15.1.10. Investments

    15.1.11. Major Companies

    15.2. Eastern Europe Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.3. Eastern Europe Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    15.4. Eastern Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.4.1. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    15.4.2. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    15.5. Eastern Europe Microbiome Market: Country Analysis

    15.6. Russia Microbiome Market

    15.7. Russia Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    15.8. Russia Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    15.9. Russia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    15.9.1. Russia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    15.9.2. Russia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    16. North America Microbiome Market

    16.1. North America Microbiome Market Overview

    16.1.1. Region Information

    16.1.2. Impact Of COVID-19

    16.1.3. Market Information

    16.1.4. Background Information

    16.1.5. Government Initiatives

    16.1.6. Regulations

    16.1.7. Regulatory Bodies

    16.1.8. Major Associations

    16.1.9. Taxes Levied

    16.1.10. Corporate Tax Structure

    16.1.11. Investments

    16.1.12. Major Companies

    16.2. North America Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.3. North America Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    16.4. North America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.4.1. North America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    16.4.2. North America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    16.5. North America Microbiome Market: Country Analysis

    16.6. USA Microbiome Market

    16.7. USA Microbiome Market Overview

    16.7.1. Country Information

    16.7.2. Impact Of COVID-19

    16.7.3. Market Information

    16.7.4. Background Information

    16.7.5. Government Initiatives

    16.7.6. Regulations

    16.7.7. Regulatory Bodies

    16.7.8. Major Associations

    16.7.9. Corporate Tax Structure

    16.7.10. Investments

    16.7.11. Major Companies

    16.8. USA Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    16.9. USA Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    16.10. USA Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    16.10.1. USA Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    16.10.2. USA Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    17. South America Microbiome Market

    17.1. South America Microbiome Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Impact Of COVID-19

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. South America Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.3. South America Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    17.4. South America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.4.1. South America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    17.4.2. South America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    17.5. South America Microbiome Market: Country Analysis

    17.6. Brazil Microbiome Market

    17.7. Brazil Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    17.8. Brazil Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    17.9. Brazil Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    17.9.1. Brazil Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    17.9.2. Brazil Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    18. Middle East Microbiome Market

    18.1. Middle East Microbiome Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. Impact Of COVID-19

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes Levied

    18.1.10. Corporate Tax Structure

    18.1.11. Investments

    18.1.12. Major Companies

    18.2. Middle East Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    18.3. Middle East Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    18.4. Middle East Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    18.4.1. Middle East Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    18.4.2. Middle East Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    19. Africa Microbiome Market

    19.1. Africa Microbiome Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Impact Of COVID-19

    19.1.4. Background Information

    19.1.5. Government Initiatives

    19.1.6. Regulations

    19.1.7. Regulatory Bodies

    19.1.8. Major Associations

    19.1.9. Taxes Levied

    19.1.10. Corporate Tax Structure

    19.1.11. Investments

    19.1.12. Major Companies

    19.2. Africa Microbiome Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

    19.3. Africa Microbiome Market, Forecast Market Growth, 2020 – 2025, 2030F Value ($ Million)

    19.4. Africa Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

    19.4.1. Africa Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, Value ($ Million)

    19.4.2. Africa Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, Value ($ Million)

    20. Global Microbiome Market Competitive Landscape

    20.1. Company Profiles

    20.2. Assembly Biosciences

    20.2.1. Company Overview

    20.2.2. Products And Services

    20.2.3. Business Strategy

    20.2.4. Financial Overview

    20.3. Enterome Bioscience

    20.3.1. Company Overview

    20.3.2. Products And Services

    20.3.3. Business Strategy

    20.3.4. Financial Overview

    20.4. Ferring Pharmaceuticals

    20.4.1. Company Overview

    20.4.2. Products And Services

    20.4.3. Financial Overview

    20.5. Vedanta BioSciences

    20.5.1. Company Overview

    20.5.2. Products And Services

    20.5.3. Business Strategy

    20.5.4. Financial Overview

    20.6. Seres Therapeutics

    20.6.1. Company Overview

    20.6.2. Products And Services

    20.6.3. Business Strategy

    20.6.4. Financial Overview

    20.7. Second Genome Inc.

    20.7.1. Company Overview

    20.7.2. Products And Services

    20.7.3. Business Strategy

    20.7.4. Financial Overview

    21. Key Mergers And Acquisitions In The Microbiome Market

    21.1. Novozymes Acquired Biota

    21.2. Lallemand Inc Acquired Biotec BetaGlucans AS

    21.3. Novozymes Acquired Microbiome Labs

    21.4. Royal DSM Acquired Erber Group

    21.5. Chr Hansen Holding A/S Acquired Jennewein Biotechnologie GmbH

    21.6. Chr Hansen Holding A/S Acquired UAS Laboratories LLC

    21.7. CanBiocin Inc Acquired Pure Cultures Inc.

    21.8. Royal DSM Acquired Glycom A/S

    21.9. Phibro Animal Health Acquired Osprey Biotechnics, Inc.

    22. Microbiome Market Opportunities & Strategies

    22.1. Global Microbiome Market In 2025 – Countries Offering Most New Opportunities

    22.2. Global Microbiome Market In 2025 – Segments Offering Most New Opportunities

    22.3. Global Microbiome Market In 2025 – Growth Strategies

    22.3.1. Market Trend Based Strategies

    22.3.2. Competitor Strategies

    23. Microbiome Market, Conclusions And Recommendations

    23.1. Conclusions

    23.2. Recommendations

    23.2.1. Product

    23.2.2. Place

    23.2.3. Price

    23.2.4. Promotion

    23.2.5. People

    24. Appendix

    24.1. Market Data Sources

    24.2. Research Methodology

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    24.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 2: Global Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 3: Global Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 4: Global Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 5: Global Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 6: Global Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 7: Global Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 8: Global Human Microbiome Therapeutics Market, Segmentation By Application,  Forecast, 2023 – 2030, $ Million
  • Table 9: Global Microbiome Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 10: Global Microbiome Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 11: Global Microbiome Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 12: Global Microbiome Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 13: Asia Pacific Food & Beverages, 2015-2020, $ Billion
  • Table 14: Asia Pacific Agriculture, 2015-2020, $ Billion
  • Table 15: Asia Pacific Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 16: Asia Pacific Oncology Drugs Market, 2015-2019, $ Billion
  • Table 17: Asia Pacific Gastrointestinal Market, 2015-2019, $ Billion
  • Table 18: Asia Pacific Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 19: Asia-Pacific Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 20: Asia-Pacific Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 21: Asia-Pacific Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 22: Asia-Pacific Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 23: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 24: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 25: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 26: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 27: China Food & Beverages, 2015-2020, $ Billion
  • Table 28: China Agriculture, 2015-2020, $ Billion
  • Table 29: China Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 30: China Oncology Drugs Market, 2015-2019, $ Billion
  • Table 31: China Gastrointestinal Market, 2015-2019, $ Billion
  • Table 32: China Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 33: China Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 34: China Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 35: China Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 36: China Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 37: China Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 38: China Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 39: China Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 40: China Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 41: India Food & Beverages, 2015-2020, $ Billion
  • Table 42: India Agriculture, 2015-2020, $ Billion
  • Table 43: India Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 44: India Oncology Drugs Market, 2015-2019, $ Billion
  • Table 45: India Gastrointestinal Market, 2015-2019, $ Billion
  • Table 46: India Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 47: India Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 48: India Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 49: India Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 50: India Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 51: India Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 52: India Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 53: India Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 54: India Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 55: Japan Food & Beverages, 2015-2020, $ Billion
  • Table 56: Japan Agriculture, 2015-2020, $ Billion
  • Table 57: Japan Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 58: Japan Oncology Drugs Market, 2015-2019, $ Billion
  • Table 59: Japan Pacific Gastrointestinal Market, 2015-2019, $ Billion
  • Table 60: Japan Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 61: Japan Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 62: Japan Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 63: Japan Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 64: Japan Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 65: Japan Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 66: Japan Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 67: Japan Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 68: Japan Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 69: Australia Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 70: Australia Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 71: Australia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 72: Australia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 73: Australia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 74: Australia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 75: Australia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 76: Australia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 77: Indonesia Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 78: Indonesia Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 79: Indonesia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 80: Indonesia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 81: Indonesia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 82: Indonesia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 83: Indonesia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 84: Indonesia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 85: South Korea Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 86: South Korea Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 87: South Korea Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 88: South Korea Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 89: South Korea Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 90: South Korea Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 91: South Korea Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 92: South Korea Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 93: Western Food & Beverages, 2015-2020, $ Billion
  • Table 94: Western Agriculture, 2015-2020, $ Billion
  • Table 95: Western Europe Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 96: Western Europe Oncology Drugs Market, 2015-2019, $ Billion
  • Table 97: Western Europe Gastrointestinal Market, 2015-2019, $ Billion
  • Table 98:Western Europe Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 99: Western Europe Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 100: Western Europe Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 101: Western Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 102: Western Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 103: Western Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 104: Western Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 105: Western Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 106: Western Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 107: UK Food & Beverages, 2015-2020, $ Billion
  • Table 108: UK Agriculture, 2015-2020, $ Billion
  • Table 109: UK Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 110: UK Oncology Drugs Market, 2015-2019, $ Billion
  • Table 111: UK Gastrointestinal Market, 2015-2019, $ Billion
  • Table 112: UK Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 113: UK Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 114: UK Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 115: UK Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 116: UK Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 117: UK Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 118: UK Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 119: UK Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 120: UK Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 121: Germany Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 122: Germany Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 123: Germany Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 124: Germany Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 125: Germany Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 126: Germany Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 127: Germany Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 128: Germany Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 129: France Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 130: France Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 131: France Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 132: France Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 133: France Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 134: France Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 135: France Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 136: France Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 137: Eastern Europe Food & Beverages, 2015-2020, $ Billion
  • Table 138: Eastern Agriculture, 2015-2020, $ Billion
  • Table 139: Eastern Europe Metabolic Drugs Market, 2015-2019, $ Billion
  • Table 140: Eastern Europe Oncology Drugs Market, 2015-2019, $ Billion
  • Table 141: Eastern Europe Gastrointestinal Market, 2015-2019, $ Billion
  • Table 142:Eastern  Europe Anti-infective Drugs Market, 2015-2019, $ Bllion
  • Table 143: Eastern Europe Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 144: Eastern Europe Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 145: Eastern Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 146: Eastern Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 147: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 148: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 149: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 150: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 151: Russia Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 152: Russia Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 153: Russia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 154: Russia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 155: Russia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 156: Russia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 157: Russia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 158: Russia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 159: North America Food & Beverages, 2015-2020, $ Billion
  • Table 160: North America Agriculture, 2015-2020, $ Billion
  • Table 161: North America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 162: North America Oncology Drugs Market, 2015-2019, $ Billion
  • Table 163: North America Gastrointestinal Market, 2015-2019, $ Billion
  • Table 164: North America Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 165: North America Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 166: North America Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 167: North America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 168: North America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 169: North America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 170: North America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 171: North America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 172: North America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 173: USA Food & Beverages, 2015-2020, $ Billion
  • Table 174: USA Agriculture, 2015-2020, $ Billion
  • Table 175: USA Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 176: USA Oncology Drugs Market, 2015-2019, $ Billion
  • Table 177: USA Gastrointestinal Market, 2015-2019, $ Billion
  • Table 178: USA Anti-infective Drugs Market, 2015-2019, $ Bullion
  • Table 179: USA Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 180: USA Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 181: USA Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 182: USA Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 183: USA Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 184: USA Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 185: USA Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 186: USA Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 187: South America Food & Beverages, 2015-2020, $ Billion
  • Table 188: South Agriculture, 2015-2020, $ Billion
  • Table 189: South America Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 190: South America Oncology Drugs Market, 2015-2019, $ Billion
  • Table 191: South America Gastrointestinal Market, 2015-2019, $ Billion
  • Table 192: South America Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 193: South America Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 194: South America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 195: South America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 196: South America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 197: South America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 198: South America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 199: South America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 200: Brazil Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 201: Brazil Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 202: Brazil Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 203: Brazil Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 204: Brazil Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 205: Brazil Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 206: Brazil Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 207: Brazil Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 208: Middle East Food & Beverages, 2015-2020, $ Billion
  • Table 209: Middle East Agriculture, 2015-2020, $ Billion
  • Table 210: Middle East Metabolic Disorder Drugs Market, 2015-2019, $ Billion
  • Table 211: Middle East Oncology Drugs Market, 2015-2019, $ Billion
  • Table 212: Middle East Gastrointestinal Market, 2015-2019, $ Billion
  • Table 213: Middle East Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 214: Middle East Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 215: Middle East Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 216: Middle East Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 217: Middle East Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 218: Middle East Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 219: Middle East Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 220: Middle East Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 221: Middle East Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 222: Africa Food & Beverages, 2015-2020, $ Billion
  • Table 223: Africa Agriculture, 2015-2020, $ Billion
  • Table 224: Africa Metabolic Disorders Drugs Market, 2015-2019, $ Billion
  • Table 225: Africa Oncology Drugs Market, 2015-2019, $ Billion
  • Table 226: Africa Gastrointestinal Market, 2015-2019, $ Billion
  • Table 227: Africa Anti-infective Drugs Market, 2015-2019, $ Billion
  • Table 228: Africa Microbiome Market, Historic, 2015 – 2020, $ Million
  • Table 229: Africa Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Table 230: Africa Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Table 231: Africa Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
  • Table 232: Africa Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Table 233: Africa Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, $ Million
  • Table 234: Africa Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Table 235: Africa Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, $ Million
  • Table 236: Global Microbiome Market, Key Competitor Estimated Ranks, 2020
  • Table 237: Seres Therapeutics – Financial Performance, 2016 – 2020, $ Billion
  • Table 238: Global Microbiome Market Size Gain ($ Million), 2020 – 2025, By Country
  • Table 239: Global Microbiome Market Size Gain ($ Million), Segmentation By End Use Industry, 2020 – 2025
  • Table 240: Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Type, 2023 – 2030
  • Table 241: Global Human Microbiome Therapeutics Market Size Gain ($ Million), Segmentation By Application, 2023 – 2030
  • Table 242: Microbiome - Market Data Sources

List Of Figures

    Figure 1: Global Microbiome Market Segmentation By End Use Industry
  • Figure 2: Global Human Microbiome Therapeutics Market Segmentation By  Type
  • Figure 3: Global Human Microbiome Therapeutics Market Segmentation By Application
  • Figure 4: Global Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 5: Global Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 6: Global Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 7: Global Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 8: Global Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 9: Global Microbiome Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 10: Global Microbiome Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 11: Asia-Pacific Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 12: Asia-Pacific Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 13: Asia-Pacific Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 14: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 15: Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 16: China Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 17: China Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 18: China Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 19: China Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 20: China Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 21: India Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 22: India Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 23: India Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 24: India Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 25: India Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 26: Japan Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 27: Japan Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 28: Japan Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 29: Japan Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 30: Japan Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 31: Australia Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 32: Australia Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 33: Australia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 34: Australia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 35: Australia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 36: Indonesia Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 37: Indonesia Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 38: Indonesia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 39: Indonesia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 40: Indonesia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 41: South Korea Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 42: South Korea Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 43: South Korea Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 44: South Korea Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 45: South Korea Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 46: Western Europe Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 47: Western Europe Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 48: Western Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 49: Western Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 50: Western Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 51: UK Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 52: UK Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 53: UK Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 54: UK Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 55: UK Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 56: Germany Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 57: Germany Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 58: Germany Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 59: Germany Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 60: Germany Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 61: France Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 62: France Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 63: France Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 64: France Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 65: France Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 66: Eastern Europe Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 67: Eastern Europe Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 68: Eastern Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 69: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 70: Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 71: Russia Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 72: Russia Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 73: Russia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 74: Russia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 75: Russia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 76: North America Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 77: North America Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 78: North America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 79: North America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 80: North America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 81: USA Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 82: USA Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 83: USA Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 84: USA Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 85: USA Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 86: South America Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 87: South America Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 88: South America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 89: South America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 90: South America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 91: Brazil Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 92: Brazil Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 93: Brazil Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 94: Brazil Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 95: Brazil Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 96: Middle East Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 97: Middle East Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 98: Middle East Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 99: Middle East Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 100: Middle East Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 101: Africa Microbiome Market, Historic, 2015 – 2020, $ Million
  • Figure 102: Africa Microbiome Market, Forecast, 2020 – 2025, 2030F, $ Million
  • Figure 103: Africa Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
  • Figure 104: Africa Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 – 2030, %
  • Figure 105: Africa Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 – 2030, %
  • Figure 106: Seres Therapeutics – Financial Performance, 2016 – 2020, $ Billion
Global Lung Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Kidney Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Interleukin Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Immunosuppressants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Inhalation Sedatives Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Insulin Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report
Respiratory Drugs Market Global Briefing 2018
View Report
Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)